Delivery Order SPE2DX22D0040-SPE2D826FA3KS
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award on January 12, 2026, valued at $49,104.00 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of January 13, 2026, represents a competitively awarded non-set-aside transaction. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $3,337.70 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a firm fixed-price delivery order with no set-aside designation, has an ultimate completion date of January 12, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $13,438.32 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at the company's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,909.60 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by January 13, 2026 and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $57,626.94 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which has an ultimate completion date of January 13, 2026, represents work to be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement, reflecting the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $160,252.80 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open market competition. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $27,771.66 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a continuation of the company's role as a critical federal medical supply vendor. The contract will be...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $242,000 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, designated as a child order under a larger indefinite delivery contract vehicle, has an ultimate completion date of January 13, 2026 and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D826FA3KSDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $58,185.03 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and no set-aside designation was used. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., also holds a larger $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031, which serves as a comprehensive global pharmaceutical support vehicle. These IDCs enable the company to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.2k | 1/11/26 |